Literature DB >> 9710237

IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes.

M Hurme1, S Santtila.   

Abstract

The genes in the IL-1 complex code for three proteins, IL-1alpha, IL-1beta and the IL-1 receptor antagonist (IL-1 Ra). The severity of a given infection is influenced by the balance between the levels of IL-1beta, the major extracellular agonist, and that of IL-1 Ra. In healthy individuals, IL-1 Ra is readily detectable in plasma but IL-1beta levels are usually undetectable. As there are polymorphisms in both of these genes, we have now analyzed whether there are allelic associations between these loci and whether these would have an influence on plasma IL-1 Ra levels. In 200 healthy blood donors, the mean plasma IL-1 Ra concentration was 681 pg/ ml. The IL-1Ra allele 2 (IL1RN*2) had a clear influence on IL-1Ra levels: its carriers had higher levels than the non-carriers (745 ng/ml vs. 627 pg/ml, p < 0.05, t-test). As marker alleles for IL-1beta we used two biallelic base-exchange polymorphisms (at positions -511 and +3953 relative to the transcriptional start site). The more rare allele of IL-1beta -511 (allele 2) was significantly associated with the presence of IL-1 Ra allele 2, but in the case of the IL-1beta +3953, the more rare allele (allele 2) was less frequent in the carriers of the IL-1 Ra allele 2. These IL-1beta allelisms did not have a direct influence on plasma IL-1Ra levels, but the enhancing effect of IL-1 Ra allele 2 on IL-1 Ra plasma levels required the presence of the IL-1beta -511 allele 2 or absence of the IL-1beta +3953 allele 2. Taken together, these results indicate that the IL-1beta gene participates in the regulation of IL-1 Ra production in vivo and that the alleles of IL-1beta and IL-1 Ra which demonstrate this cooperative effect are often associated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710237     DOI: 10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  84 in total

1.  Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta after live yellow fever vaccination.

Authors:  U T Hacker; S Erhardt; K Tschöp; T Jelinek; S Endres
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

2.  Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients.

Authors:  Weidong Ji; Ning Li; Kang Ju; Hong Zheng; Chuang Yang; Ping Xu; Silu Chen; Aiai Cao; Xue Chen; Lanting Guo
Journal:  Neurol Sci       Date:  2014-11-04       Impact factor: 3.307

3.  Genetics of the bone response to bisphosphonate treatments.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

4.  Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers.

Authors:  L Joos; L McIntyre; J Ruan; J E Connett; N R Anthonisen; T D Weir; P D Paré; A J Sandford
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

5.  Genetic predisposition for inflammation exacerbates effects of striatal iron content on cognitive switching ability in healthy aging.

Authors:  Ana M Daugherty; David A Hoagey; Kristen M Kennedy; Karen M Rodrigue
Journal:  Neuroimage       Date:  2018-10-25       Impact factor: 6.556

Review 6.  Genetic predisposition and renal allograft failure: implication of non-HLA genetic variants.

Authors:  Faisal Khan; Swati Agrawal; Suraksha Agrawal
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

7.  Effect of serum interleukin-1 receptor antagonist level on survival of patients with non-small cell lung cancer.

Authors:  Murat Yigit; Serkan Değirmencioğlu; Erhan Ugurlu; Arzu Yaren
Journal:  Mol Clin Oncol       Date:  2017-03-15

8.  Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases.

Authors:  A Nemetz; M Tóth; M A García-González; T Zágoni; J Fehér; A S Peña; Z Tulassay
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

9.  Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain.

Authors:  Xiao-Min Wang; Tian-Xia Wu; May Hamza; Edward S Ramsay; Sharon M Wahl; Raymond A Dionne
Journal:  Pain       Date:  2006-10-27       Impact factor: 6.961

10.  Interleukin-1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise.

Authors:  Richard A Dennis; Todd A Trappe; Pippa Simpson; Chad Carroll; B Emma Huang; Radhakrishnan Nagarajan; Edward Bearden; Cathy Gurley; Gordon W Duff; William J Evans; Kenneth Kornman; Charlotte A Peterson
Journal:  J Physiol       Date:  2004-08-26       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.